Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease

Sung Soo Ahn, Byung Woo Yoo, Seung Min Jung, Sang Won Lee, YongBeom Park, Jason Jungsik Song

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective. To evaluate the clinical significance of the 2016 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR)/Pediatric Rheumatology International Trials Organization (PRINTO) classification criteria for macrophage activation syndrome (MAS) in patients with adult-onset Still disease (AOSD). Methods.We performed a retrospective analysis of patients with AOSD with fever who were admitted to Severance Hospital between 2005 and 2016. The patients with AOSD were evaluated for MAS using the 2016 classification criteria for MAS. Clinical features, laboratory findings, and overall survival were analyzed. Logistic regression analysis was used to evaluate the factors associated with in-hospital mortality. Results. Among 64 patients with AOSD, 36 (56.3%) were classified as having MAS. The overall survival rate was significantly lower in patients with MAS than in those without (67% vs 100%, p < 0.001). Multivariate analysis showed that a low erythrocyte sedimentation rate, a low albumin level, an increase in ferritin of over 2 folds, and the development of MAS on admission were significantly associated with mortality in patients with AOSD. Conclusion. The 2016 EULAR/ACR/PRINTO classification criteria for MAS are potentially useful for the identification of patients with AOSD at high risk for a poor outcome. Febrile patients with AOSD should be monitored with the 2016 classification criteria for MAS in the early diagnosis and proper treatment of MAS. (First Release April 15 2017; J Rheumatol 2017;44:996-1003; doi:10.3899/jrheum.161286).

Original languageEnglish
Pages (from-to)996-1003
Number of pages8
JournalJournal of Rheumatology
Volume44
Issue number7
DOIs
Publication statusPublished - 2017 Jul 1

Fingerprint

Macrophage Activation Syndrome
Adult-Onset Still's Disease
Rheumatology
Rheumatic Diseases
Organizations
Pediatrics
Fever
Blood Sedimentation
Ferritins
Hospital Mortality
Early Diagnosis
Albumins
Multivariate Analysis
Survival Rate
Logistic Models
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Ahn, Sung Soo ; Yoo, Byung Woo ; Jung, Seung Min ; Lee, Sang Won ; Park, YongBeom ; Song, Jason Jungsik. / Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease. In: Journal of Rheumatology. 2017 ; Vol. 44, No. 7. pp. 996-1003.
@article{aedb0b397abd401f81d3c0ec2dbe65fe,
title = "Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease",
abstract = "Objective. To evaluate the clinical significance of the 2016 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR)/Pediatric Rheumatology International Trials Organization (PRINTO) classification criteria for macrophage activation syndrome (MAS) in patients with adult-onset Still disease (AOSD). Methods.We performed a retrospective analysis of patients with AOSD with fever who were admitted to Severance Hospital between 2005 and 2016. The patients with AOSD were evaluated for MAS using the 2016 classification criteria for MAS. Clinical features, laboratory findings, and overall survival were analyzed. Logistic regression analysis was used to evaluate the factors associated with in-hospital mortality. Results. Among 64 patients with AOSD, 36 (56.3{\%}) were classified as having MAS. The overall survival rate was significantly lower in patients with MAS than in those without (67{\%} vs 100{\%}, p < 0.001). Multivariate analysis showed that a low erythrocyte sedimentation rate, a low albumin level, an increase in ferritin of over 2 folds, and the development of MAS on admission were significantly associated with mortality in patients with AOSD. Conclusion. The 2016 EULAR/ACR/PRINTO classification criteria for MAS are potentially useful for the identification of patients with AOSD at high risk for a poor outcome. Febrile patients with AOSD should be monitored with the 2016 classification criteria for MAS in the early diagnosis and proper treatment of MAS. (First Release April 15 2017; J Rheumatol 2017;44:996-1003; doi:10.3899/jrheum.161286).",
author = "Ahn, {Sung Soo} and Yoo, {Byung Woo} and Jung, {Seung Min} and Lee, {Sang Won} and YongBeom Park and Song, {Jason Jungsik}",
year = "2017",
month = "7",
day = "1",
doi = "10.3899/jrheum.161286",
language = "English",
volume = "44",
pages = "996--1003",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "7",

}

Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease. / Ahn, Sung Soo; Yoo, Byung Woo; Jung, Seung Min; Lee, Sang Won; Park, YongBeom; Song, Jason Jungsik.

In: Journal of Rheumatology, Vol. 44, No. 7, 01.07.2017, p. 996-1003.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease

AU - Ahn, Sung Soo

AU - Yoo, Byung Woo

AU - Jung, Seung Min

AU - Lee, Sang Won

AU - Park, YongBeom

AU - Song, Jason Jungsik

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Objective. To evaluate the clinical significance of the 2016 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR)/Pediatric Rheumatology International Trials Organization (PRINTO) classification criteria for macrophage activation syndrome (MAS) in patients with adult-onset Still disease (AOSD). Methods.We performed a retrospective analysis of patients with AOSD with fever who were admitted to Severance Hospital between 2005 and 2016. The patients with AOSD were evaluated for MAS using the 2016 classification criteria for MAS. Clinical features, laboratory findings, and overall survival were analyzed. Logistic regression analysis was used to evaluate the factors associated with in-hospital mortality. Results. Among 64 patients with AOSD, 36 (56.3%) were classified as having MAS. The overall survival rate was significantly lower in patients with MAS than in those without (67% vs 100%, p < 0.001). Multivariate analysis showed that a low erythrocyte sedimentation rate, a low albumin level, an increase in ferritin of over 2 folds, and the development of MAS on admission were significantly associated with mortality in patients with AOSD. Conclusion. The 2016 EULAR/ACR/PRINTO classification criteria for MAS are potentially useful for the identification of patients with AOSD at high risk for a poor outcome. Febrile patients with AOSD should be monitored with the 2016 classification criteria for MAS in the early diagnosis and proper treatment of MAS. (First Release April 15 2017; J Rheumatol 2017;44:996-1003; doi:10.3899/jrheum.161286).

AB - Objective. To evaluate the clinical significance of the 2016 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR)/Pediatric Rheumatology International Trials Organization (PRINTO) classification criteria for macrophage activation syndrome (MAS) in patients with adult-onset Still disease (AOSD). Methods.We performed a retrospective analysis of patients with AOSD with fever who were admitted to Severance Hospital between 2005 and 2016. The patients with AOSD were evaluated for MAS using the 2016 classification criteria for MAS. Clinical features, laboratory findings, and overall survival were analyzed. Logistic regression analysis was used to evaluate the factors associated with in-hospital mortality. Results. Among 64 patients with AOSD, 36 (56.3%) were classified as having MAS. The overall survival rate was significantly lower in patients with MAS than in those without (67% vs 100%, p < 0.001). Multivariate analysis showed that a low erythrocyte sedimentation rate, a low albumin level, an increase in ferritin of over 2 folds, and the development of MAS on admission were significantly associated with mortality in patients with AOSD. Conclusion. The 2016 EULAR/ACR/PRINTO classification criteria for MAS are potentially useful for the identification of patients with AOSD at high risk for a poor outcome. Febrile patients with AOSD should be monitored with the 2016 classification criteria for MAS in the early diagnosis and proper treatment of MAS. (First Release April 15 2017; J Rheumatol 2017;44:996-1003; doi:10.3899/jrheum.161286).

UR - http://www.scopus.com/inward/record.url?scp=85021827856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021827856&partnerID=8YFLogxK

U2 - 10.3899/jrheum.161286

DO - 10.3899/jrheum.161286

M3 - Article

C2 - 28412707

AN - SCOPUS:85021827856

VL - 44

SP - 996

EP - 1003

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 7

ER -